We focus on the patients and develop solutions to meet their real-world needs.
Our best-in-class antibody therapeutics built on novel biology enable us to pursue a pipeline-in-a-product strategy.
Our VEGA Program focuses on addressing the overlooked needs of people living with von Willebrand disease (VWD) and other bleeding disorders.
© 2025 STAR Therapeutics Inc.
We look forward to connecting with you